Benoxaprofen
From Wikipedia, the free encyclopedia
 |
|
|
Benoxaprofen
|
|
| Systematic (IUPAC) name | |
| 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C16H12ClNO3 |
| Mol. mass | 301.72438 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Benoxaprofen is a non-steroidal anti-inflammatory drug. It was marketed by Eli Lilly and Company under the brand name Oraflex. Lilly suspended sales of Oraflex in 1982 after reports from the British government and the U.S. Food and Drug Administration of adverse effects and deaths linked to the drug.
[edit] References
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||
